Cynthia Louise Palmer

This inventor holds 38 USPTO granted patents and 1 published patent application, plus 5 CIPO patents and 4 EPO patents, primarily in Cancer Therapeutics. Top assignees: Agouron Pharmaceuticals, Inc., Pfizer Corporation. Active years: 1996-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cynthia Louise Palmer. Retrieved from https://idiyas.com/inventor/cynthia-louise-palmer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 38 (Patent Applications = 1)

% Patents Active = 78.9

CIPO Patents = 5

EPO Patents = 4 (Patent Applications = 8)

Average Co-Inventor Count = 5.3

ph-index = 8

Forward Citations = 632(Granted Patents)

Location History:

La Mesa, CA (US) (1996 - 2022)
San Diego, CA (US) (2003 - 2022)

Company Filing History:

26 out of 174

Agouron Pharmaceuticals, Inc.

Years Active: 1996-2025

Loading Chart...

Areas of Expertise:

CDK Inhibitors

Antiproliferative Agents

Quinazoline Derivatives

Pyridopyrimidine Compounds

Macrocyclic Derivatives

Protein Kinase Inhibitors

Thienopyridines

AICARFT Inhibitors

5-Thiapyrimidinone Compounds

Optically Pure Compounds

Tricyclic Ring Compounds

GARFT Inhibitors

38 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12378232 - Cyclin dependent kinase inhibitors (2025-08-05),

2. 11396512 - CDK2/4/6 inhibitors (2022-07-26),

3. 11220494 - Cyclin dependent kinase inhibitors (2022-01-11),

4. 11203594 - Anti-proliferative agents for treating PAH (2021-12-21),

5. 10800783 - CDK2/4/6 inhibitors (2020-10-13),

6. 10766884 - Cyclin dependent kinase inhibitors (2020-09-08),

7. 10662204 - Substituted quinazoline and pyridopyrimidine derivatives useful as anticancer agents (2020-05-26),

8. 10590115 - Tetrahydroquinazoline derivatives useful as anticancer agents (2020-03-17),

9. 9133215 - Macrocyclic derivatives for the treatment of diseases (2015-09-15),

10. 8916593 - Alkoxy-substituted 2-aminopyridines as ALK inhibitors (2014-12-23),

11. 8680111 - Macrocyclic derivatives for the treatment of diseases (2014-03-25),

12. 7772246 - Pyrazole compounds as RAF inhibitors (2010-08-10),

13. 7141587 - Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use (2006-11-28),

14. 7053107 - Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use (2006-05-30),

15. 7045528 - Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use (2006-05-16),

Title: The Innovations of Cynthia Louise Palmer

Introduction

Cynthia Louise Palmer is a prominent inventor based in La Mesa, California. With an impressive portfolio of 37 patents, Palmer has significantly contributed to the field of pharmaceutical sciences, particularly in developing treatments for cancer through innovative compounds.

Latest Patents

Among her latest inventions are CDK2/4/6 inhibitors. This innovation pertains to compounds of general Formula (I), which are cyclin-dependent kinase inhibitors. These compounds, or their pharmaceutically acceptable salts, include specific R-groups and are integral to pharmaceutical compositions designed for treating abnormal cell growth, including various forms of cancer. Palmer's work highlights the potential of these compounds in the medical field, offering new hope for effective treatments.

Career Highlights

Cynthia Palmer has had an impactful career with notable pharmaceutical companies such as Agouron Pharmaceuticals and Pfizer Corporation. Her efforts in research and development have propelled numerous projects aimed at combating cancer, showcasing her dedication to advancing medical science. Her prolific work has earned her recognition among peers and within the larger scientific community.

Collaborations

Throughout her career, Palmer has collaborated with distinguished colleagues, including Michael D. Varney and William H. Romines. These partnerships have been instrumental in her success, fostering an environment of innovation and creativity that has brought many breakthroughs to life.

Conclusion

Cynthia Louise Palmer is a leading figure in the field of pharmaceutical inventions, with her extensive patent portfolio underscoring her significant contributions to medical science. Her work on CDK inhibitors represents a crucial advancement in cancer treatment, solidifying her reputation as an influential inventor and collaborator. As research continues to evolve, Palmer's innovations will undoubtedly play a vital role in shaping the future of healthcare.

Profile summary based on public USPTO records.